热门资讯> 正文
选择医疗任命新首席执行官，宣布执行领导层变动
2025-09-03 05:40
- Select Medical Holdings (NYSE:SEM) said on Tuesday it has appointed Thomas P. Mullin as CEO, effective immediately.
- Mullin succeeds David S. Chernow, who becomes Vice Chairman of the board after serving as CEO since 2014.
- Mullin, a 17-year company veteran, most recently served as co-president overseeing 140 hospitals in the company’s critical illness recovery and inpatient rehabilitation divisions.
- Other leadership changes include the appointment of John A. Saich as sole President and John F. Duggan as Executive Vice President, General counsel and Secretary.
- Michael E. Tarvin will transition to Senior Executive Vice President of legal services.
- Source: Press Release
More on Select Medical
- Select Medical Holdings Corporation (SEM) Q2 2025 Earnings Call Transcript
- Select Medical: Despite A Change In The Regulatory Environment, This Prospect Is Worth Considering
- Select Medical reaffirms $5.3B–$5.5B 2025 revenue outlook as inpatient rehab expansion accelerates
- Select Medical GAAP EPS of $0.32 beats by $0.07, revenue of $1.34B misses by $10M
- Seeking Alpha’s Quant Rating on Select Medical
推荐文章
港股异动 | “港股通新宠”再次狂飙！截至发稿，佰泽医疗狂飙超62%，药捷安康-B大涨43%
新股首日 | “全球激光雷达龙头”禾赛-W涨逾7%！中签一手赚328港元
华盛早报 | 深夜大涨！谷歌市值突破3万亿美元大关；特朗普欲废除美股季报制度，改为仅披露半年报
9月16日外盘头条：马斯克增持10亿美元特斯拉股票 OpenAI推出新版GPT-5 特朗普敦促共和党团结 通过拨款法案
美股机会日报 | 特朗普怒斥：美联储主席能力不足！马斯克增持特斯拉后股价狂飙超8%
“三重利好”点燃特斯拉股价情绪！马斯克押宝Optimus机器人量产，这些概念也要爆？
新股暗盘 | “全球激光雷达龙头”禾赛-W涨近6%，中签一手账面浮盈248港元
港股异动 | 药捷安康上市不到3个月飙升超2000%，市值升破1100亿港元
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
